-
Democrats, Trump hold final rallies before midterm elections
-
African players in Europe: Defender Hakimi's historic hat-trick
-
Japan urges US to enforce discipline after second Marine arrest
-
Struggling Slavia face Arsenal as grim record looms
-
'Remarkable' rookie Lendeborg scores 37 as Warriors beat Clippers
-
Vikings suffer first loss while Broncos edge Chiefs in NFL
-
ExxonMobil urged to re-think Papua New Guinea gas project
-
South Korea to double spending on AI and chips in 2027
-
Asian stocks mixed as tech sector struggles to rebound from selloff
-
On All Saints' Day, Philippine mountain town honours dead with fire
-
India's royals find new power in their past
-
Years on from fall of IS, French jihadists face justice in Iraq
-
Irish bookshops help meet UK demand for Sally Rooney novels
-
Point of Law favourite at Australia's 'race that stops a nation'
-
NFL Vikings suffer first loss while Broncos edge Chiefs
-
'Kid' Antonelli gets affectionate tributes from all quarters
-
Host of fresh faces in Australia white-ball squads to face England
-
Hamilton accuses Leclerc of wrecking Ferrari hopes
-
NFL linebacker Campbell to remain hospitalized overnight
-
enVVeno Medical to Showcase the enVVe System at 38th Annual Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium
-
Gladstone Alternative Income Fund Announces Monthly Cash Distribution for November 2026
-
Nexscient Announces Expanded Customer Engagements and New Commercial Agreements in Autonomous Driving and Humanoid Robotics Data Services
-
Vicapsys Life Sciences Provides Shareholder Update on VICAPSYN(TM) Program Advancing Toward Phase 1 Human Clinical Trial, Vertically Integrated With the Company's Indian Health Service Strategy
-
XCF Global Withdraws Reverse Stock Split Proposal; Reaffirms Growth Strategy and Shareholder Support
-
Gladstone Commercial Corporation Earnings Call and Webcast Information
-
cbdMD Completes Acquisition of the Operating Assets and Brands of Twinlab, including Twinlab, Reserveage and Metabolife Brands, Expanding Into Broader Wellness
-
Palo Alto Collaboration Company Opens Waitlist for Pana, a Personal AI That Builds Tools That Stay Yours
-
Anthony, Linder & Cacomanolis Recognized in Chambers & Partners Spotlight Florida 2027 for Securities Law Excellence
-
Tectonic Metals Intersects 5.61 g/t Au Over 41.15 m, Including 12.94 g/t Au Over 13.72 m, Within 2.86 g/t Au Over 91.44 m, Strengthening Evidence for a Second Gold System at the Flat Gold Project
-
IRS Pushes Tax Deadlines to February 1, 2027 for Washington Wildfire Counties - Clear Start Tax Explains What the Postponement Does Not Pause
-
Optimistivity Unveils Refreshed Brand and Expanded Digital Product Range
-
GameSquare to Report Q3 2026 Financial Results on November 16, 2026
-
AsiaFIN Holdings Corp. to Host Q3 2026 Earnings Webcast from New York City
-
Predictiv AI Awarded Metrolinx Master Agreement for On-Demand Transit Software and Related Services
-
Electric Metals (USA) Limited Announces Results of Annual Meeting of Stockholders
-
iAsk.ai Surpasses One Billion Searches
-
International Battery Metals Announces Second Quarter Fiscal 2027 Financial Results Conference Call and Webcast
-
Electrovaya Ranks Fourth Among Canada's Enterprise - Industry Leaders in Deloitte's Technology Fast 50(TM) Program
-
BEING rather than HAVING. A fascinating, practical STORY.
-
Hospital AI Funding Faces a Reality Check: New 2027 Outlook Puts Outsourcing Savings to the Test
-
Jaguar Mining Provides Update on Permitting of the Onças de Pitangui Development Project, Minas Gerais, Brazil
-
Ur-Energy Announces Retirement of CFO Roger Smith, Names VP Finance Jade Walle as Successor
-
DataMEDS AI Enters Into Agreement for Commercial Supply of Six Peptides Recommended by FDA Advisory Committee
-
Aer Lingus and MTech Mobility Launch Live Ground Operations Technology Programme Across Three Irish Airports
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 02
-
Medical Care Technologies Inc. (OTCID:MDCE) Delivers Stronger Melanoma Scan Beta Readout on Expanded Human-Submitted Dataset
-
With Expansion into Naval Shipbuilding, Hanwha Philly Shipyard Names 25-Year Shipbuilding Veteran as President
-
ASGA's Attack on Menhaden Science Exposes Its Own Double Standard
-
Family Hospice Care Celebrates 20 Years of Light, Love and Legacy During National Home Health Month and Hospice and Palliative Care Month
-
Hop-on (OTCID: HPNN) Subsidiary Digitalage Completes Core Cre-ator Platform Build, Moves to Enterprise Technology Licensing
New 'highly virulent' HIV strain discovered in the Netherlands
Oxford researchers announced Thursday the discovery of a highly virulent strain of HIV that has been lurking in the Netherlands for decades, but because of the effectiveness of modern treatments, is "no cause for alarm."
Their analysis, published Thursday in the journal "Science," showed that patients infected with what they call the "VB variant" had 3.5 to 5.5 times higher levels of the virus in their blood than those infected with other variants, as well as a more rapidly fading immune system.
However, the study also found that after starting treatment, individuals with the VB variant had similar immune system recovery and survival to individuals with other HIV variants.
"There's no cause for alarm with this new viral variant," said Oxford epidemiologist Chris Wymant, the lead author on the paper, in an interview with AFP.
The variant likely arose in the late 1980s and early 1990s in the Netherlands, according to the researchers, but began to decline around 2010.
Since modern interventions still seem to work on the variant, the research team believes that widespread HIV treatment in the Netherlands did not contribute to the virus's evolution, and that early detection and treatment are paramount.
"Our findings emphasize the importance of World Health Organization guidance that individuals at risk of acquiring HIV have access to regular testing to allow early diagnosis, followed by immediate treatment," said co-author Christophe Fraser, also an Oxford researcher, in a press release announcing the findings.
The work also supports the theory that viruses can evolve to become more virulent, a widely-hypothesized idea for which few real-world examples have been found.
The Delta variant of the novel coronavirus was another recent example.
The discovery of the HIV variant should therefore "be a warning that we should never be overconfident about saying viruses will just evolve to become milder," said Wymant to AFP.
In total, the team found 109 people infected with the VB variant, with only four living outside the Netherlands, but still in western Europe.
- 500 mutations -
The HIV virus is constantly evolving, so much so that each person infected has a slightly different version.
The VB variant, however, was found to have over 500 mutations.
"Finding a new variant is normal, but finding a new variant with unusual properties is not -- especially one with increased virulence," Wyman explained.
The research team first identified the VB variant in 17 HIV positive individuals by parsing a broad data set from the BEEHIVE project, a data collection and analysis initiative in Europe and Uganda.
Because 15 of the 17 were from the Netherlands, they further studied data from 6,700 HIV-positive Dutch individuals, identifying 92 others.
The earliest appearance of the VB variant in their data was found in someone diagnosed in 1992 who had an early version of the variant, and the most recent in 2014.
Other researchers have since found other individuals with the variant diagnosed after 2014.
Doctors usually measure HIV's deterioration of the immune system by monitoring the decline of CD4 T-cells, which are targeted by the HIV virus and pivotal for protecting the body against infections.
In patients infected with the VB variant, CD4 decline occurred twice as fast compared to other variants, "placing them at risk of developing AIDS much more rapidly," the researchers said.
In addition to its increased impact on the immune system, the team also found the VB variant to be more highly transmissible.
They came to that conclusion after comparing the different versions of the VB variant drawn from infected patients.
The fact that they were so similar suggests that the virus passed rapidly to someone else before it could accumulate many mutations.
- 'Critical' to diagnose and treat early -
"Because the VB variant causes a more rapid decline in immune system strength, this makes it critical that individuals are diagnosed early and start treatment as soon as possible," the press statement noted.
"This limits the amount of time HIV can damage an individual's immune system and jeopardize their health," added Fraser.
Fraser is also the principal investigator of the BEEHIVE project, which was launched in 2014 to gather data on how mutations in the HIV virus can lead to varying degrees of severity among patients.
Those differences have previously been thought to mostly relate to the strength of individuals' own immune systems.
The researchers said they could not identify which genetic mutation in the VB variant caused its virulence, but they hope future studies will be able to.
B.Finley--AMWN